Dr. Keith Ferdinand, a leading expert in hypertension at Tulane University, joins hosts to discuss the groundbreaking BPROAD trial. They explore the impact of intensive blood pressure management on cardiovascular outcomes in patients with type 2 diabetes. The conversation highlights the trade-offs of rigorous blood pressure targets and strategies for managing uncontrolled hypertension. Future directions in treatment, including cognitive health implications and advanced therapies like renal denervation, add to the intrigue, promising exciting developments in cardiovascular care.